Lamotrigine Shortage Update: What Patients Need to Know in 2026

If you take lamotrigine for epilepsy or bipolar disorder and have recently found yourself staring at an empty pharmacy shelf, you're part of a growing group of patients running into availability issues — even though lamotrigine is not officially on the FDA's national drug shortage list in 2026. This guide breaks down the current situation and what you can do to protect your supply.

Current Lamotrigine Shortage Status in 2026

As of 2026, lamotrigine is not listed on the FDA drug shortage database as a nationwide shortage. The drug is manufactured by multiple generic pharmaceutical companies in the United States, which generally provides a buffer against single-manufacturer disruptions.

However, "not in a national shortage" does not mean "universally available." At the local pharmacy level, patients are regularly reporting:

Specific formulations (ODT, XR, oral suspension) being out of stock at chain pharmacies

Certain dose strengths being unavailable at their usual pharmacy

Their regular manufacturer's version being substituted without notice

Regional availability that varies significantly by geography and pharmacy chain

A Brief History of Lamotrigine Shortages

Lamotrigine has a history of supply disruptions globally, even if major US shortages have been less frequent:

January 2020: Taro Pharmaceuticals initiated a voluntary nationwide recall for a specific lot of lamotrigine tablets in the US due to cross-contamination concerns.

2024–2025: Canada experienced significant and recurring lamotrigine supply disruptions, with multiple manufacturers citing production issues. The Canadian government acknowledged the need for better manufacturer communication.

2024–2026: Australia's Therapeutic Goods Administration (TGA) listed several lamotrigine formulations as being in shortage or having limited availability, with some anticipated shortages extending into 2026.

Ongoing UK issues: A study of epilepsy patients in the UK found that 65.2% reported experiencing a shortage of lamotrigine at some point — the shortages often happening at the local supply chain level rather than at the manufacturer level.

What's Causing Lamotrigine Availability Problems?

Multiple factors contribute to lamotrigine availability challenges:

Global API supply chain pressure. The active pharmaceutical ingredient (API) for lamotrigine is manufactured globally. Disruptions in raw material sourcing — due to manufacturing incidents, geopolitical issues, or transportation delays — can ripple through to US generic manufacturers.

Multiple formulations, uneven stocking. Lamotrigine exists in IR tablets, chewable tablets, ODT tablets, extended-release tablets, and now an oral suspension (Subvenite, approved September 2025). Pharmacies prioritize their highest-volume products. Less common formulations may be routinely special-ordered rather than stocked.

Thin generic manufacturer margins. Generic lamotrigine can be purchased for as little as $4-$10 per month with discount programs. Those low prices mean thin profit margins for manufacturers, making continued investment in production capacity a business challenge.

High demand volume. With over 10 million lamotrigine prescriptions written annually in the US alone, even a relatively small supply disruption can translate into widespread patient-level shortages.

Why Missing Lamotrigine Doses Is a Medical Emergency

For epilepsy patients, lamotrigine is not a drug you can simply skip for a few days while waiting for a restock. Missing doses or abruptly stopping can cause:

Breakthrough seizures — even in patients who have been seizure-free for years

Status epilepticus — prolonged, life-threatening seizures requiring emergency treatment

Loss of driving privileges — most states require a seizure-free period (often 6-12 months) before a patient can legally drive; a breakthrough seizure restarts the clock

Mood destabilization — for bipolar patients, missing lamotrigine can trigger depression or mixed mood episodes

What to Do Right Now If You Can't Find Lamotrigine

Call your prescriber immediately. Don't wait until you've run out. Let your doctor know about the supply issue — they may have samples, be able to call the pharmacy directly, or discuss a temporary bridge strategy.

Search multiple pharmacies. Don't stop at the first "out of stock" answer. Independent pharmacies, grocery store pharmacies, and pharmacies across town may have your formulation.

Use a pharmacy locator service. medfinder calls pharmacies near you to identify which ones have your medication in stock, saving you significant time when you're in an urgent situation.

Ask for a partial fill. If a pharmacy has some but not all of your supply, they can dispense a partial fill to bridge you while they restock.

Do not ration your doses. Taking half doses without physician guidance can reduce your protection against seizures without the benefit of a proper supervised taper. Call your doctor instead.

How to Protect Your Lamotrigine Supply Going Forward

Always refill 7-10 days before you run out of your current supply

Ask your prescriber for a 90-day supply prescription to reduce refill frequency

Find an independent pharmacy that can reliably special-order for you and build a long-term relationship with them

Keep a written list of 3-5 local pharmacies with phone numbers that you can rotate through

The Bottom Line

Lamotrigine is not in a declared national shortage in 2026, but localized availability issues are real and can put patients with epilepsy or bipolar disorder in a dangerous position. Acting early — refilling well before you run out and having a backup plan — is the single most important thing you can do. When you do run into a supply problem, services like medfinder can help you locate stock quickly so you don't have to navigate this alone.

If supply issues are ongoing and your prescriber is discussing alternatives, see: Alternatives to Lamotrigine If You Can't Fill Your Prescription.